Calcium nephrolithiasis, metabolic syndrome and the cardiovascular risk

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3008-3010

  Gambaro, Giovanni ^a   Ferraro, Pietro Manuel ^a   Capasso, Giovambattista ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; GAMMA LINOLENIC ACID;

ARTERIAL STIFFNESS; ARTICLE; BONE MASS; CALCIUM OXALATE STONE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NEPHROLITHIASIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; URIC ACID STONE;

CALCIUM; FEMALE; HUMANS; KIDNEY CALCULI; MALE; METABOLIC SYNDROME X;

EID: 84864633022     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs139     Document Type: Article

References (23)

1. Sakhaee K, Capolongo G, Maalouf NM et al. Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant 2012; 27: 3201-3209.
2. Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 2008; 7: 304-309.
3. Cupisti A. Update on nephrolithiasis: beyond symptomatic urinary tract obstruction. J Nephrol 2011; 24Suppl 18S25-S29.
4. Baggio B, Gambaro G. Calcium nephrolithiasis: a systemic disease. It J Miner Electrol Metab 1996; 10: 47-48.
5. Baggio B, Gambaro G, Zambon S et al. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis. J Am Soc Nephrol 1996; 7: 613-620.
6. Messa P, Londero D, Massarino F et al. Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers. Nephrol Dial Transplant 2000; 15: 1388-1393.
7. Baggio B, Budakovic A, Nassuato M et al. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 2000; 58: 1278-1284.
8. Rodgers A, Lewandowski S, Allie-Hamdulay S et al. Evening primrose oil supplementation increases citraturia and decreases other urinary risk factors for calcium oxalate urolithiasis. J Urol 2009; 182: 2957-2963.
9. Taylor EN, Stampfer MJ, Curhan GC. Fatty acid intake and incidence of nephrolithiasis. Am J Kidney Dis 2005; 45: 267-274.
10. Caudarella R, Vescini F, Buffa A et al. Osteoporosis and urolithiasis. Urol Int 2004; 72Suppl 117-19.
11. Letavernier E, Traxer O, Daudon M et al. Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. Clin J Am Soc Nephrol 2011; 6: 1149-1154.
12. West B, Luke A, Durazo-Arvizu RA et al. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis 2008; 51: 741-747.
13. Maalouf NM, Cameron MA, Moe OWet al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007; 2: 883-888.
14. Rule AD, Roger VL, Melton LJ, 3rd et al. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 2010; 21: 1641-1644.
15. Domingos F, Serra A. Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 2011; 26: 864-868.
16. Knoll T, Schubert AB, Fahlenkamp D et al. Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J Urol 2011; 185: 1304-1311.
17. Ljunghall S, Hedstrand H. Renal stones and coronary heart disease. Acta Med Scand 1976; 199: 481-485.
18. Gambaro G, Favaro S, D'Angelo A. Risk for renal failure in nephrolithiasis. Am J Kidney Dis 2001; 37: 233-243.
19. Rule AD, Bergstralh EJ, Melton LJ, 3rd et al. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 804-811.
20. Cappuccio FP, Siani A, Barba G et al. A prospective study of hypertension and the incidence of kidney stones in men. J Hypertens 1999; 17: 1017-1022.
21. Borghi L, Meschi T, Guerra A et al. Essential arterial hypertension and stone disease. Kidney Int 1999; 55: 2397-2406.
22. Fabris A, Lupo A, Fantin F et al. Abnormal arterial stiffness and bone density in calcium renal stone formers. J Am Soc Nephrol 2011; 22: 388.
23. Toussaint ND, Lau KK, Strauss BJ et al. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 2008; 23: 586-593